Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 hours
Awards & highlights
Study Summary
This trial will compare the effectiveness of two types of regional anesthesia for hip fractures in terms of pain control and rates of delirium.
Who is the study for?
This trial is for emergency department patients with hip fractures, specifically femoral neck or intertrochanteric fractures. Participants must consent to the procedure and not have allergies to local anesthetics. Those with severe injuries causing instability, serious unstable medical conditions, or hemodynamic instability cannot join.Check my eligibility
What is being tested?
The study compares two regional anesthesia techniques: PENG (Pericapsular Nerve Group) block and FICB (Fascia Iliaca Compartment Block), in terms of pain control effectiveness for hip fracture patients. The hypothesis suggests that PENG might be more effective based on prior studies.See study design
What are the potential side effects?
Potential side effects may include discomfort at the injection site, possible nerve damage, infection risk at the injection area, bleeding complications due to needle insertion, and allergic reactions to the anesthetic used.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pain score
Secondary outcome measures
Opioid use
Trial Design
2Treatment groups
Active Control
Group I: PENGActive Control1 Intervention
Patients with hip fracture randomized to receive PENG block
Group II: FICBActive Control1 Intervention
Patients with hip fracture randomized to received FICB
Find a Location
Who is running the clinical trial?
University of VirginiaLead Sponsor
753 Previous Clinical Trials
1,244,981 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My blood pressure and heart rate are stable.I do not agree to participate in the study.I have severe, unstable health conditions.I have a broken hip bone.
Research Study Groups:
This trial has the following groups:- Group 1: PENG
- Group 2: FICB
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Can participants still join this experiment?
"The clinical trial registry on clinicialtrials.gov confirms that this study, which was introduced to the public on September 30th 2022 is not presently looking for participants. Nevertheless, 374 other trials are actively seeking patients at the time of writing."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger